J-C Wang Selected Research

N- (1- (4- methoxybenzenesulfonyl)- 2,3- dihydro- 1H- indol- 7- yl)- 1- oxyisonicotinamide

4/2014

Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J-C Wang Research Topics

Disease

4	Ischemia 05/2014 - 01/2013
3	Neoplasms (Cancer) 04/2014 - 10/2007
3	Reperfusion Injury 01/2013 - 01/2013
2	Respiratory Insufficiency (Respiratory Failure) 02/2018 - 01/2013
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2014 - 09/2013
2	Lung Injury 01/2013 - 01/2013
1	Nasopharyngeal Carcinoma 01/2020
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 02/2018
1	Acute Lung Injury 02/2018
1	Marijuana Abuse (Cannabis Abuse) 01/2018
1	Mental Disorders (Mental Disorder) 01/2018
1	Tobacco Use Disorder (Nicotine Dependence) 05/2016
1	Atherosclerosis 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Hyperglycemia 01/2016
1	Asthma (Bronchial Asthma) 05/2014
1	Acute Kidney Injury (Acute Renal Failure) 05/2014
1	Hypersensitivity (Allergy) 05/2014
1	Adenocarcinoma of Lung 09/2013
1	Inflammation (Inflammations) 01/2013
1	Lung Diseases (Lung Disease) 01/2013
1	Pneumonia (Pneumonitis) 01/2013
1	Wounds and Injuries (Trauma) 01/2013
1	Anemia 07/2012
1	Connective Tissue Diseases (Connective Tissue Disease) 07/2012
1	Ataxia (Dyssynergia) 07/2012
1	Leukopenia 07/2012
1	Prostatic Neoplasms (Prostate Cancer) 10/2007
1	Glaucoma 04/2004

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2013 - 10/2007
2	salicylhydroxamic acid (SHAM)IBA 05/2014 - 01/2013
2	Hydroxyl RadicalIBA 05/2014 - 01/2013
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2014 - 09/2013
2	CurcuminIBA 01/2013 - 01/2013
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	Long Noncoding RNAIBA 01/2020
1	Valproic Acid (Depakote)FDA LinkGeneric 02/2018
1	Biological ProductsIBA 01/2018
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 05/2016
1	Nicotine FDA Link 05/2016
1	Triglycerides (Triacylglycerol)IBA 01/2016
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Leukotriene D4IBA 05/2014
1	Methacholine Chloride (Methacholine)FDA Link 05/2014
1	verlukastIBA 05/2014
1	Vinca AlkaloidsIBA 04/2014
1	N- (1- (4- methoxybenzenesulfonyl)- 2,3- dihydro- 1H- indol- 7- yl)- 1- oxyisonicotinamideIBA 04/2014
1	Taxoids (Taxanes)IBA 04/2014
1	calcein AMIBA 04/2014
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 04/2014
1	Coloring Agents (Dyes)IBA 04/2014
1	TubulinIBA 04/2014
1	ErbB Receptors (EGF Receptor)IBA 09/2013
1	Histone Deacetylase InhibitorsIBA 09/2013
1	Pharmaceutical PreparationsIBA 09/2013
1	Tyrosine Kinase InhibitorsIBA 09/2013
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2013
1	3- (1- benzenesulfonyl- 2,3- dihydro- 1H- indol- 5- yl)- N- hydroxyacrylamideIBA 09/2013
1	MM Form Creatine KinaseIBA 01/2013
1	Free RadicalsIBA 01/2013
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2013
1	CytokinesIBA 01/2013
1	ChemokinesIBA 01/2013
1	Troponin IIBA 01/2013
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 07/2012
1	Antinuclear AntibodiesIBA 07/2012
1	mortalinIBA 10/2007
1	Fluorouracil (Carac)FDA LinkGeneric 04/2004

Therapy/Procedure

1	Lung Transplantation 01/2013
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2013